1. Home
  2. BNTC vs AMRN Comparison

BNTC vs AMRN Comparison

Compare BNTC & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • AMRN
  • Stock Information
  • Founded
  • BNTC 1995
  • AMRN 1989
  • Country
  • BNTC United States
  • AMRN Ireland
  • Employees
  • BNTC N/A
  • AMRN N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • AMRN Biotechnology: Pharmaceutical Preparations
  • Sector
  • BNTC Health Care
  • AMRN Health Care
  • Exchange
  • BNTC Nasdaq
  • AMRN Nasdaq
  • Market Cap
  • BNTC 365.1M
  • AMRN 339.8M
  • IPO Year
  • BNTC N/A
  • AMRN 1993
  • Fundamental
  • Price
  • BNTC $13.06
  • AMRN $17.04
  • Analyst Decision
  • BNTC Strong Buy
  • AMRN Strong Sell
  • Analyst Count
  • BNTC 5
  • AMRN 1
  • Target Price
  • BNTC $26.60
  • AMRN $12.00
  • AVG Volume (30 Days)
  • BNTC 304.0K
  • AMRN 148.6K
  • Earning Date
  • BNTC 11-14-2025
  • AMRN 10-29-2025
  • Dividend Yield
  • BNTC N/A
  • AMRN N/A
  • EPS Growth
  • BNTC N/A
  • AMRN N/A
  • EPS
  • BNTC N/A
  • AMRN N/A
  • Revenue
  • BNTC N/A
  • AMRN $226,733,000.00
  • Revenue This Year
  • BNTC N/A
  • AMRN N/A
  • Revenue Next Year
  • BNTC N/A
  • AMRN N/A
  • P/E Ratio
  • BNTC N/A
  • AMRN N/A
  • Revenue Growth
  • BNTC N/A
  • AMRN N/A
  • 52 Week Low
  • BNTC $9.10
  • AMRN $7.08
  • 52 Week High
  • BNTC $17.15
  • AMRN $20.90
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 39.49
  • AMRN 51.57
  • Support Level
  • BNTC $12.47
  • AMRN $15.74
  • Resistance Level
  • BNTC $13.94
  • AMRN $16.65
  • Average True Range (ATR)
  • BNTC 1.27
  • AMRN 0.71
  • MACD
  • BNTC -0.18
  • AMRN 0.05
  • Stochastic Oscillator
  • BNTC 29.06
  • AMRN 88.69

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About AMRN Amarin Corporation plc

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Share on Social Networks: